Physician
Arkansas Pathology Associates PA
Arkansas Pathology Associates PA was paid $864K by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 30% of everything it billed.
33Billing provider infoARKANSAS PATHOLOGY ASSOCIATES PA
LITTLE ROCK, AR 72207
LITTLE ROCK, AR 72207
33aNPI1033171467assigned 04/03/2006
33bProvider typeCytopathology Physician
28Total paid$864K
24GClaims153,629
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,320 | $108K | |
| 2019 | 51,175 | $59K | |
| 2020 | 36,664 | $210K | |
| 2021 | 16,954 | $230K | |
| 2022 | 4,269 | $95K | |
| 2023 | 6,258 | $63K | |
| 2024incomplete | 15,989 | $100K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 30% | 38,567 | 14,790 | $256K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 20% | 18,524 | 7,870 | $172K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 20% | 18,579 | 7,929 | $169K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 9.0% | 8,548 | 3,504 | $78K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 6.8% | 3,558 | 1,817 | $59K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 5.2% | 11,617 | 4,767 | $45K |
| 88307 | 4.8% | 5,140 | 1,524 | $41K | |
| 88342 | 2.4% | 7,352 | 2,500 | $21K | |
| 88304 | 1.1% | 3,611 | 1,108 | $9K | |
| 88312 | <1% | 1,519 | 541 | $3K | |
| 88141 | <1% | 2,165 | 788 | $2K | |
| 84165 | <1% | 2,676 | 1,119 | $2K |
82 more codes
| 88341 | <1% | 137 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,229 | $939.95 |
| 85060 | <1% | 842 | $676.60 | |
| 86901 | <1% | 545 | $476.46 | |
| 80053 | Comprehensive metabolic panel | <1% | 2,601 | $453.20 |
| 81001 | <1% | 834 | $408.74 | |
| 88302 | <1% | 88 | $302.99 | |
| 86334 | <1% | 517 | $297.76 | |
| 88300 | <1% | 40 | $297.27 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,464 | $249.39 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,607 | $215.05 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,009 | $180.00 |
| 88184 | <1% | 101 | $111.61 | |
| 86850 | <1% | 299 | $81.62 | |
| 83690 | <1% | 374 | $69.82 | |
| 81025 | <1% | 463 | $65.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 534 | $59.40 |
| 84484 | <1% | 361 | $57.88 | |
| 82803 | <1% | 229 | $37.94 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 59 | $33.00 |
| 83735 | <1% | 455 | $24.66 | |
| 82947 | <1% | 963 | $24.41 | |
| 83605 | <1% | 170 | $15.71 | |
| 86140 | <1% | 17 | $15.22 | |
| 80143 | <1% | 26 | $15.00 | |
| 82310 | <1% | 337 | $13.58 | |
| 82374 | <1% | 340 | $13.20 | |
| 82435 | <1% | 343 | $12.76 | |
| 85610 | <1% | 335 | $10.99 | |
| 84460 | <1% | 193 | $10.79 | |
| 86900 | <1% | 609 | $10.70 | |
| 84075 | <1% | 192 | $10.61 | |
| 84450 | <1% | 193 | $10.60 | |
| 82247 | <1% | 245 | $10.39 | |
| 82040 | <1% | 192 | $10.29 | |
| 81003 | <1% | 851 | $8.08 | |
| 84155 | <1% | 192 | $8.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 197 | $6.81 |
| 86592 | <1% | 188 | $6.28 | |
| 82565 | <1% | 341 | $6.00 | |
| 84295 | <1% | 398 | $6.00 | |
| 84520 | <1% | 347 | $6.00 | |
| 84132 | <1% | 384 | $6.00 | |
| 82962 | <1% | 230 | $4.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 84 | $4.01 |
| 80320 | <1% | 83 | $2.28 | |
| 81015 | <1% | 49 | $1.29 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 97 | $0.00 |
| 83006 | 0% | 156 | $0.00 | |
| 84702 | 0% | 57 | $0.00 | |
| 80347 | 0% | 19 | $0.00 | |
| 82948 | 0% | 30 | $0.00 | |
| 87899 | 0% | 18 | $0.00 | |
| 85014 | 0% | 77 | $0.00 | |
| 87186 | 0% | 35 | $0.00 | |
| 86480 | 0% | 16 | $0.00 | |
| 82775 | 0% | 17 | $0.00 | |
| 80326 | 0% | 19 | $0.00 | |
| 82570 | 0% | 12 | $0.00 | |
| 80349 | 0% | 78 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 174 | $0.00 |
| 87088 | 0% | 75 | $0.00 | |
| 83021 | 0% | 199 | $0.00 | |
| 82553 | 0% | 81 | $0.00 | |
| 86880 | 0% | 16 | $0.00 | |
| 88185 | 0% | 101 | $0.00 | |
| 85027 | 0% | 127 | $0.00 | |
| 85730 | 0% | 132 | $0.00 | |
| 82261 | 0% | 199 | $0.00 | |
| 83498 | 0% | 16 | $0.00 | |
| 87040 | 0% | 14 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 89 | $0.00 |
| 87077 | 0% | 34 | $0.00 | |
| 88720 | 0% | 390 | $0.00 | |
| 82379 | 0% | 15 | $0.00 | |
| 82017 | 0% | 16 | $0.00 | |
| 82550 | 0% | 99 | $0.00 | |
| 84703 | 0% | 15 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 14 | $0.00 |
| 83520 | 0% | 16 | $0.00 | |
| 82139 | 0% | 16 | $0.00 | |
| 87430 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARTLEIN, STACY (BUSINESS MANAGER)